rheumatoid arthritis
Scipher Medicine Buys Software Firm CrossBridge
Precision immunology firm Scipher said the acquisition of Philadelphia-based CrossBridge is intended to strengthen its data management and analytics capabilities.
Gene Expression, Histology Reveal Clues for Targeted Rheumatoid Arthritis Treatment
Histological profiling and RNA sequencing helped identify synovial biopsy features for predicting targeted biologic therapy response in rheumatoid arthritis.
Myriad Genetics Settles Anti-Kickback Lawsuit Related to Vectra DA
Myriad will pay $45.25 million to the federal and California state governments and $2.75 million to the whistleblower in exchange for dismissal of the case and all claims against it.
The company is hoping to gain a local coverage determination from CMS this year as it solidifies data for its first assay and works on building out a larger menu.
Scipher Medicine Nabs $110M in Financing
The company is advancing a pipeline of RNA-based immune disease assays, spearheaded by its PrismRA test to guide therapy for rheumatoid arthritis.